Abstract:The contributions of commensal fungi to human health and disease are not well understood. Candida species such as C. albicans and C. glabrata are opportunistic pathogenic fungi and common colonizers of the human intestinal tract. They have been shown to affect the host immune system and interact with the gut microbiome and pathogenic microorganisms. Therefore, Candida species could be expected to play important ecological roles in the host gastrointestinal tract. Previously, our group demonstrated that pre-colonization of mice with C. albicans protected them against lethal C. difficile infection (CDI). Here, we show that mice pre-colonized with C. glabrata succumbed to CDI more rapidly than mice that were not pre-colonized suggesting an enhancement in C. difficile pathogenesis. Further, when C. difficile was added to pre-formed C. glabrata biofilms, an increase in matrix and overall biomass was observed. These effects were also shown with C. glabrata clinical isolates. Interestingly, the presence of C. difficile increased C. glabrata biofilm susceptibility to caspofungin, indicating potential effects on the fungal cell wall. Defining this intricate and intimate relationship will lead to an understanding of the role of Candida species in the context of CDI and novel aspects of Candida biology. IMPORTANCE Most microbiome studies have only considered the bacterial populations while ignoring other members of the microbiome such as fungi, other eukaryotic microorganisms, and viruses. Therefore, the role of fungi in human health and disease has been significantly understudied compared to their bacterial counterparts. This has generated a significant gap in knowledge that has negatively impacted disease diagnosis, understanding, and the development of therapeutics. With the development of novel technologies, we now have an understanding of mycobiome composition, but we do not understand the roles of fungi in the host. Here, we present findings showing that Candida glabrata, an opportunistic pathogenic yeast that colonizes the mammalian gastrointestinal tract, can impact the severity and outcome of a Clostridioides difficile infection (CDI) in a murine model. These findings bring attention to fungal colonizers during CDI, a bacterial infection of the gastrointestinal tract.

Adaptive immunity induces mutualism between commensal eukaryotes

A Human Commensal-Pathogenic Fungus Suppresses Host Immunity Via Targeting TBK1

Commensal enteric bacteria lipopolysaccharide impairs host defense against disseminated Candida albicans fungal infection

Competitive fungal commensalism mitigates candidiasis pathology

Interplay between host and Candida albicans during commensal gut colonization

The Interactions Between <i>Candida albicans</i> and Mucosal Immunity

Bacteria-derived short-chain fatty acids as potential regulators of fungal commensalism and pathogenesis

P145 Phagocyte responses to gut-derived C. albicans are modified in inflammatory bowel disease

Mucosal Immunity to Gut Fungi in Health and Inflammatory Bowel Disease

Pre-colonization with the fungus Candida glabrata exacerbates infection by the bacterial pathogen Clostridioides difficile in a murine model

Tipping the Balance: C. albicans Adaptation in Polymicrobial Environments

Social Transfer of Pathogenic Fungus Promotes Active Immunisation in Ant Colonies.

Commensal fungi Candida albicans modulates dietary high-fat induced alterations in metabolism, immunity, and gut microbiota

Immune Interactions with Pathogenic and Commensal Fungi

Commensal Yeast Promotes Salmonella Typhimurium Virulence

Synergistic cross-kingdom host cell damage between Candida albicans and Enterococcus faecalis

Fungal symbiont transmitted by free-living mice promotes type 2 immunity

Tryptophan as a Central Hub for Host/Microbial Symbiosis

Symbiotic Firmicutes establish mutualism with the host via innate tolerance and resistance to control systemic immunity

Mucosal fungi promote gut barrier function and social behavior via Type 17 immunity

Intestinal fungi and antifungal secretory immunoglobulin A in Crohn’s disease